No abstract available
MeSH terms
-
Antineoplastic Agents, Alkylating / adverse effects
-
Brain Neoplasms / drug therapy*
-
DNA, Viral / blood
-
DNA, Viral / drug effects
-
Dacarbazine / adverse effects
-
Dacarbazine / analogs & derivatives*
-
Glioblastoma / drug therapy*
-
Hepatitis B / chemically induced*
-
Hepatitis B / immunology
-
Hepatitis B / physiopathology
-
Humans
-
Immunocompromised Host / immunology
-
Immunosuppression Therapy / adverse effects*
-
Lamivudine / therapeutic use
-
Liver / drug effects
-
Liver / physiopathology
-
Liver / virology
-
Male
-
Middle Aged
-
Patient Selection
-
Reverse Transcriptase Inhibitors / therapeutic use
-
Risk Factors
-
Spinal Neoplasms / secondary*
-
Spinal Neoplasms / therapy
-
Temozolomide
-
Treatment Outcome
-
Viral Load
-
Virus Activation / drug effects
-
Virus Activation / genetics
Substances
-
Antineoplastic Agents, Alkylating
-
DNA, Viral
-
Reverse Transcriptase Inhibitors
-
Lamivudine
-
Dacarbazine
-
Temozolomide